Honorable Lois W. Kolkhorst, Chair, Senate Committee on Health & Human Services
FROM:
Jerry McGinty, Director, Legislative Budget Board
IN RE:
SB1619 by Perry (Relating to the determination of prescription drug reimbursement amounts under the Medicaid vendor drug program.), As Introduced
The fiscal implications of the bill cannot be determined due to the potential for costs related to the exclusion of discount prices from prescription drug reimbursement amounts under the Medicaid vendor drug program being unknown.
The bill would direct the Health and Human Services Commission (HHSC) to exclude discount prices offered for a prescription drug from the usual and customary price. According to HHSC, the bill would have no fiscal impact on the agency, because currently pharmacies determine the usual and customary price, not HHSC. The fiscal implications of pharmacies excluding discount prices offered for prescription drugs, including third-party discount cards, cannot be determined at this time.
Local Government Impact
No fiscal implication to units of local government is anticipated.